Listed

Boston Scientific Corp: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Feb 23, 2021 and accepted by EDGAR at Feb 23, 2021, 16:21 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$9.91bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2020-01-01 to 2020-12-31$3.46bnus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2020-01-01 to 2020-12-31$6.45bnus-gaap:GrossProfit
Selling, general and administrative12 months2020-01-01 to 2020-12-31$3.79bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2020-01-01 to 2020-12-31−$80.0mus-gaap:OperatingIncomeLoss
Interest expense12 months2020-01-01 to 2020-12-31$361.0mus-gaap:InterestExpense
Income tax12 months2020-01-01 to 2020-12-31$2.0mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2020-01-01 to 2020-12-31−$82.0mus-gaap:ProfitLoss
Diluted EPS12 months2020-01-01 to 2020-12-31−$0.08us-gaap:EarningsPerShareDiluted
Basic EPS12 months2020-01-01 to 2020-12-31−$0.08us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2020-01-01 to 2020-12-311,416,700,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2020-01-01 to 2020-12-31$1.51bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$376.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2020-01-01 to 2020-12-31$28.0mus-gaap:PaymentsOfDividends
Share repurchases12 months2020-01-01 to 2020-12-31$535.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-12-31$1.73bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$6.69bnus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$30.78bnus-gaap:Assets
Current liabilitiesAt period end2020-12-31$3.68bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2020-12-31$13.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2020-12-31$15.33bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0000885725-21-000008. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.